SPY749.95−0.59%QQQ674.36−0.81%BTC/USD68,196.45−4.45%DIA521.10−0.39%GLD354.98−0.13%TLT79.380.00%
BenzingaPremium Services
Premium Services

General

Zai Lab Advances Atopic Dermatitis Candidate Toward Potential Quarterly Maintenance Dosing
Zai Lab Advances Atopic Dermatitis Candidate Toward Potential Quarterly Maintenance Dosing
Your AI Health Advice May Be Influenced by Drug Ads, Study Finds
Your AI Health Advice May Be Influenced by Drug Ads, Study Finds
Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
Your AI Health Advice May Be Influenced by Drug Ads, Study Finds
Your AI Health Advice May Be Influenced by Drug Ads, Study Finds
Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Rise as Nvidia CEO Exit Remains in Focus— CSCO, AMAT, NU in Focus(UPDATED)
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Rise as Nvidia CEO Exit Remains in Focus— CSCO, AMAT, NU in Focus(UPDATED)
FDA Reportedly Shelves Fast-Track Drug Review Pilot Program During Leadership Vacuum: Report
FDA Reportedly Shelves Fast-Track Drug Review Pilot Program During Leadership Vacuum: Report

General Recent News

Anthropic's Dario Amodei Promises 'Age of Miracles' ― Medicine Isn't Buying It
Anthropic's Dario Amodei Promises 'Age of Miracles' ― Medicine Isn't Buying It
Anthropic CEO Dario Amodei predicts AI will make major diseases obsolete within a decade. Pharma leaders and scientists aren't buying the timeline.
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options
FDA clears Tandem Diabetes Care's Tandem Mobi as the first tubeless automated insulin delivery system with seven-day wear launching in 2027.
Novo Nordisk Scores EU Win For Hemophilia Drug, Advances Sickle Cell Treatment Toward Approval
Novo Nordisk Scores EU Win For Hemophilia Drug, Advances Sickle Cell Treatment Toward Approval
Novo Nordisk secures EU approval for hemophilia therapy Frehemgo and submits US and European applications for sickle cell drug etavopivat.
Bessent Points Finger at Lutnick as White House Feud Over Nvidia Erupts
Bessent Points Finger at Lutnick as White House Feud Over Nvidia Erupts
Scott Bessent publicly blamed Howard Lutnick over the Nvidia China chip scandal as Lutnick’s exit odds surged
Pasithea's PAS-004 Shrinks Skin Tumors in All 15 Evaluable Patients
Pasithea's PAS-004 Shrinks Skin Tumors in All 15 Evaluable Patients
Pasithea Therapeutics shares positive Phase 1/1b NF1 clinical data for PAS-004, showing tumor reductions and clean safety ahead of Phase 2.
UnitedHealthcare Policy Assessment Urges Clearer Provider Guidance
UnitedHealthcare Policy Assessment Urges Clearer Provider Guidance
External consultants praise UnitedHealthcare's evidence-based medical policy process while recommending clearer templates and documentation.
GTA 6 Nears Launch With $1 Billion in Estimated Preorders: Bettors See 97% Chance of Record First-Day Sales
GTA 6 Nears Launch With $1 Billion in Estimated Preorders: Bettors See 97% Chance of Record First-Day Sales
GTA 6 has an estimated $1.09 billion in preorders as bettors give it a 97% chance of breaking GTA V’s first-day sales record
SpaceX's Historic Starship Flight 15 Still Awaiting FAA Approval Hours Before Launch
SpaceX's Historic Starship Flight 15 Still Awaiting FAA Approval Hours Before Launch
SpaceX is still awaiting FAA approval for Starship Flight 15 just hours before Friday’s planned launch.
SemiAnalysis Suspects US Intelligence Role in Jensen Huang’s Exit as China Chip Crackdown Looms
SemiAnalysis Suspects US Intelligence Role in Jensen Huang’s Exit as China Chip Crackdown Looms
SemiAnalysis says U.S. intelligence may have helped push Jensen Huang out as Washington weighs tougher China chip restrictions
Chamath Palihapitiya Says Nvidia Oversight Would Be A ‘Disaster’ After Jensen Huang's Exit, Warns Against Repeating Microsoft’s DOJ Era
Chamath Palihapitiya Says Nvidia Oversight Would Be A ‘Disaster’ After Jensen Huang's Exit, Warns Against Repeating Microsoft’s DOJ Era
Chamath Palihapitiya warns Nvidia oversight after Jensen Huang’s exit could hurt U.S. AI leadership and repeat Microsoft’s DOJ era.
Billionaire Investor Dan Loeb Bought Back Into Union Pacific and Norfolk Southern In Q2 — Here's Where the $85 Billion Rail Merger Stands
Billionaire Investor Dan Loeb Bought Back Into Union Pacific and Norfolk Southern In Q2 — Here's Where the $85 Billion Rail Merger Stands
Dan Loeb’s Third Point rebuilt stakes in Union Pacific and Norfolk Southern as their $85 billion merger awaits regulatory approval.
SpaceX’s Next Starship Test Could Be Worth Far More Than a Rocket Landing, Morgan Stanley Says — Top Analyst Sees SPCX Stock Soaring to $300
SpaceX’s Next Starship Test Could Be Worth Far More Than a Rocket Landing, Morgan Stanley Says — Top Analyst Sees SPCX Stock Soaring to $300
Morgan Stanley analyst Adam Jonas says Elon Musk-led SpaceX’s first Starship double catch could boost the company's businesses.
Connect With Us
instagramlinkedinyoutube
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved